Abstract

Research Article

Haemodynamic, Biochemical and Respiratory Implications of total Bronchoalveolar Lavage in Pulmonary Alveolar Proteinosis

María Nieves Balaguer Cartagena*, Ester Villareal Tello, Begoña Balerdi Pérez, Andrés Briones Gómez, Raquel Martínez Tomás and Enrique Cases Viedma

Published: 17 June, 2023 | Volume 7 - Issue 2 | Pages: 023-028

Introduction: Total bronchoalveolar lavage (BAL) continues to be the treatment of choice for alveolar proteinosis (AP), facilitating the removal of lipoprotein material. The purpose of this article is to evaluate the impact of haemodynamic, biochemical, and respiratory parameters, as well as the complications and evolution of patients undergoing this procedure. 
Methods: Retrospective, observational, and descriptive study of BAL. The technique was performed in the Intensive Care Unit. Blood gases, blood pressure, central venous pressure, body temperature, and fluid balance were analyzed. 
Results: Including eight patients, thirty-eight BAL were performed from 2008 to 2021. 
The mean instillation of saline at each session was 13.464 ± 4.002 ml per lung. No significant changes were observed before and after BAL in heart rate and blood pressure. Mean central venous pressure increased by 2.59 cm H20. The pO2 initial was 126 mmHg with a final mean of 69.7 mmHg, with statistical significance. The pCO2, HCO3 and pH parameters remained stable. 
Complications were observed during fifteen of the thirty-eight BAL (nine with arterial hypotension, three with glottic oedema, one acute pulmonary oedema, one pneumothorax, and one cardiorespiratory arrest). In terms of evolution, one case had a clinical-radiological resolution, one case of exits, one required lung transplantation, and the remaining five remained stable. 
Conclusion: This study demonstrates that the procedure, is well tolerated haemodynamically and that the biochemical alterations to which the patient is subjected are not compromised. With few complications and good results in delaying the progression of AP.

Read Full Article HTML DOI: 10.29328/journal.acr.1001071 Cite this Article Read Full Article PDF

Keywords:

Total bronchoalveolar lavage; Pulmonary alveolar proteinosis; Rare diseases

References

  1. Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med. 1958 Jun 5;258(23):1123-42. doi: 10.1056/NEJM195806052582301. PMID: 13552931.
  2. McCarthy C, Avetisyan R, Carey BC, Chalk C, Trapnell BC. Prevalence and healthcare burden of pulmonary alveolar proteinosis. Orphanet J Rare Dis. 2018 Jul 31;13(1):129. doi: 10.1186/s13023-018-0846-y. PMID: 30064481; PMCID: PMC6069872.
  3. Shah PL, Hansell D, Lawson PR, Reid KB, Morgan C. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax. 2000 Jan;55(1):67-77. doi: 10.1136/thorax.55.1.67. PMID: 10607805; PMCID: PMC1745595.
  4. Trapnell BC, Whitsett JA, Nakata K. Pulmonary alveolar proteinosis. N Engl J Med. 2003 Dec 25;349(26):2527-39. doi: 10.1056/NEJMra023226. PMID: 14695413.
  5. Mazzone P, Thomassen MJ, Kavuru M. Our new understanding of pulmonary alveolar proteinosis: what an internist needs to know. Cleve Clin J Med. 2001 Dec;68(12):977-8, 981-2, 984-5 passim. doi: 10.3949/ccjm.68.12.977. PMID: 11765122.
  6. Murch CR, Carr DH. Computed tomography appearances of pulmonary alveolar proteinosis. Clin Radiol. 1989 May;40(3):240-3. doi: 10.1016/s0009-9260(89)80180-1. PMID: 2752679.
  7. Rodríguez Portal JA. Treatment of Adult Primary Alveolar Proteinosis. Arch Bronconeumol. 2015 Jul;51(7):344-9. English, Spanish. doi: 10.1016/j.arbres.2015.02.003. Epub 2015 Apr 17. PMID: 25896950.
  8. Beccaria M, Luisetti M, Rodi G, Corsico A, Zoia MC, Colato S, Pochetti P, Braschi A, Pozzi E, Cerveri I. Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J. 2004 Apr;23(4):526-31. doi: 10.1183/09031936.04.00102704. PMID: 15083749.
  9. Kavuru MS, Sullivan EJ, Piccin R, Thomassen MJ, Stoller JK. Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1143-8. doi: 10.1164/ajrccm.161.4.9906044. PMID: 10764303.
  10. Cheng SL, Chang HT, Lau HP, Lee LN, Yang PC. Pulmonary alveolar proteinosis: treatment by bronchofiberscopic lobar lavage. Chest. 2002 Oct;122(4):1480-5. doi: 10.1378/chest.122.4.1480. PMID: 12377884.
  11. Soyez B, Borie R, Menard C, Cadranel J, Chavez L, Cottin V, Gomez E, Marchand-Adam S, Leroy S, Naccache JM, Nunes H, Reynaud-Gaubert M, Savale L, Tazi A, Wemeau-Stervinou L, Debray MP, Crestani B. Rituximab for auto-immune alveolar proteinosis, a real life cohort study. Respir Res. 2018 Apr 25;19(1):74. doi: 10.1186/s12931-018-0780-5. PMID: 29695229; PMCID: PMC5918901.
  12. Iftikhar H, Nair GB, Kumar A. Update on Diagnosis and Treatment of Adult Pulmonary Alveolar Proteinosis. Ther Clin Risk Manag. 2021 Aug 10;17:701-710. doi: 10.2147/TCRM.S193884. PMID: 34408422; PMCID: PMC8364424.
  13. Ramirez J, Schultz RB, Dutton RE. Pulmonary alveolar proteinosis: a new technique and rationale for treatment. Arch Intern Med. 1963 Sep;112:419-31. doi: 10.1001/archinte.1963.03860030173021. PMID: 14045290.
  14. Garber B, Albores J, Wang T, Neville TH. A plasmapheresis protocol for refractory pulmonary alveolar proteinosis. Lung. 2015 Apr;193(2):209-11. doi: 10.1007/s00408-014-9678-2. Epub 2015 Jan 4. PMID: 25557091.
  15. Diaz-Mendoza J, Celis Valdiviezo E, Patel NM, Simoff MJ. One-session bilateral sequential whole lung lavage (OSBSWLL) for the management of pulmonary alveolar proteinosis. BMC Pulm Med. 2021 Nov 9;21(1):358. doi: 10.1186/s12890-021-01734-w. PMID: 34749694; PMCID: PMC8575669.
  16. Rogers RM, Levin DC, Gray BA, Moseley LW Jr. Physiologic effects of bronchopulmonary lavage in alveolar proteinosis. Am Rev Respir Dis. 1978 Aug;118(2):255-64. doi: 10.1164/arrd.1978.118.2.255. PMID: 697176.
  17. Seymour JF, Presneill JJ, Schoch OD, Downie GH, Moore PE, Doyle IR, Vincent JM, Nakata K, Kitamura T, Langton D, Pain MC, Dunn AR. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med. 2001 Feb;163(2):524-31. doi: 10.1164/ajrccm.163.2.2003146. PMID: 11179134.
  18. Takaki M, Tanaka T, Komohara Y, Tsuchihashi Y, Mori D, Hayashi K, Fukuoka J, Yamasaki N, Nagayasu T, Ariyoshi K, Morimoto K, Nakata K. Recurrence of pulmonary alveolar proteinosis after bilateral lung transplantation in a patient with a nonsense mutation in CSF2RB. Respir Med Case Rep. 2016 Aug 13;19:89-93. doi: 10.1016/j.rmcr.2016.06.011. PMID: 27595063; PMCID: PMC4995526.
  19. Gal AA, Bryan JA, Kanter KR, Lawrence EC. Cytopathology of pulmonary alveolar proteinosis complicating lung transplantation. J Heart Lung Transplant. 2004 Jan;23(1):135-8. doi: 10.1016/s1053-2498(03)00032-9. PMID: 14734139.
  20. Montón C, Peña R, Marín A. Proteinosis alveolar. Tratamiento mediante lavado pulmonar completo [Alveolar proteinosis. Treatment with total lung lavage]. Arch Bronconeumol. 2000 May;36(5):291-2. Spanish. doi: 10.1016/s0300-2896(15)30172-1. PMID: 10916671.
  21. Cheng SL, Chang HT, Lau HP, Lee LN, Yang PC. Pulmonary alveolar proteinosis: treatment by bronchofiberscopic lobar lavage. Chest. 2002 Oct;122(4):1480-5. doi: 10.1378/chest.122.4.1480. PMID: 12377884.
  22. Murray MJ, De Ruyter ML, Harrison BA. Bilateral lung washings for pulmonary alveolar proteinosis. J Bronchol. 1998; 5: 324-6.
  23. Fernández del Campo R, Lozares Sánchez A, Francisco Corral G, Prieto del Portillo I, Pérez Rodríguez E, Maudes Rodríguez A. Lavado broncoalveolar bilateral secuencial: caso clínico, método y discusión [Bilateral bronchoalveolar lavage: a clinical case, method and discussion]. Med Intensiva. 2007 Oct;31(7):407-10. Spanish. doi: 10.1016/s0210-5691(07)74846-5. PMID: 17942065.
  24. Smith JD, Millen JE, Safar P, Robin ED. Intrathoracic pressure, pulmonary vascular pressures and gas exchange during pulmonary lavage. Anesthesiology. 1970 Oct;33(4):401-5. doi: 10.1097/00000542-197010000-00007. PMID: 5512328.
  25. Smith BB, Torres NE, Hyder JA, Barbara DW, Gillespie SM, Wylam ME, Smith MM. Whole-lung Lavage and Pulmonary Alveolar Proteinosis: Review of Clinical and Patient-centered Outcomes. J Cardiothorac Vasc Anesth. 2019 Sep;33(9):2453-2461. doi: 10.1053/j.jvca.2019.03.047. Epub 2019 Mar 28. PMID: 31307910.
  26. Hunter Guevara LR, Gillespie SM, Klompas AM, Torres NE, Barbara DW. Whole-lung lavage in a patient with pulmonary alveolar proteinosis. Ann Card Anaesth. 2018 Apr-Jun;21(2):215-217. doi: 10.4103/aca.ACA_184_17. PMID: 29652291; PMCID: PMC5914230.
  27. Stokes JW, Katsis JM, Gannon WD, Rice TW, Lentz RJ, Rickman OB, Avasarala SK, Benson C, Bacchetta M, Maldonado F. Venovenous extracorporeal membrane oxygenation during high-risk airway interventions. Interact Cardiovasc Thorac Surg. 2021 Nov 22;33(6):913-920. doi: 10.1093/icvts/ivab195. PMID: 34293146; PMCID: PMC8632782.
  28. Claypool WD, Rogers RM, Matuschak GM. Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis). Chest. 1984 Apr;85(4):550-8. doi: 10.1378/chest.85.4.550. PMID: 6368143.
  29. Campo I, Luisetti M, Griese M, Trapnell BC, Bonella F, Grutters J, Nakata K, Van Moorsel CH, Costabel U, Cottin V, Ichiwata T, Inoue Y, Braschi A, Bonizzoni G, Iotti GA, Tinelli C, Rodi G; WLL International Study Group. Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures. Orphanet J Rare Dis. 2016 Aug 31;11(1):115. doi: 10.1186/s13023-016-0497-9. PMID: 27577926; PMCID: PMC5006612.

Figures:

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?